Jim Simons’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$853K Buy
222,075
+176,870
+391% +$725K ﹤0.01% 2346
2025
Q4
$168K Buy
45,205
+4,745
+12% +$40.7K ﹤0.01% 2914
2025
Q3
$571K Buy
40,460
+16,600
+70% +$259K ﹤0.01% 2734
2025
Q2
$458K Sell
23,860
-17,346
-42% -$271K ﹤0.01% 2879
2025
Q1
$456K Sell
41,206
-4,577
-10% -$54.6K ﹤0.01% 2782
2024
Q4
$762K Buy
45,783
+42,171
+1,168% +$526K ﹤0.01% 2631
2024
Q3
$36.7K Buy
+3,612
New +$107K ﹤0.01% 3379
2024
Q2
Sell
-30,159
Closed -$1M 3833
2024
Q1
$1M Buy
30,159
+7,999
+36% +$405K ﹤0.01% 2480
2023
Q4
$1.8M Buy
22,160
+14,227
+179% +$1.16M ﹤0.01% 2018
2023
Q3
$1.29M Buy
+7,933
New +$1.87M ﹤0.01% 2126
2023
Q2
Sell
-9,640
Closed -$2.66M 4172
2023
Q1
$2.66M Buy
9,640
+7,507
+352% +$2.76M ﹤0.01% 1851
2022
Q4
$826K Sell
2,133
-1,194
-36% -$337K ﹤0.01% 2647
2022
Q3
$795K Buy
+3,327
New +$891K ﹤0.01% 2635
2022
Q2
Sell
-3,427
Closed -$2.33M 4468
2022
Q1
$2.33M Sell
3,427
-10,566
-76% -$6.36M ﹤0.01% 2126
2021
Q4
$9.67M Buy
+13,993
New +$10.3M 0.01% 1091

Other funds holding OM

Jim Simons's OM Position: Q1 2026 in Review

Jim Simons increased its Outset Medical (OM) stake by 391% in Q1 2026, buying an estimated $725K and bringing the position to 222,075 shares worth $853K. The position accounts for ﹤0.01% of the portfolio, ranked #2346.

Jim Simons first reported a position in OM in Q4 2021 and has held it in 15 quarters since. The position peaked at $9.67M in Q4 2021. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Jim Simons held 222,075 shares of Outset Medical worth $853K as of Q1 2026.
  • Jim Simons bought 176,870 Outset Medical shares in Q1 2026, an estimated $725K.
  • Outset Medical made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2346 holding.
  • Jim Simons first reported a position in Outset Medical in Q4 2021 and has held it in 15 quarters since.
  • Jim Simons's Outset Medical position peaked at $9.67M in Q4 2021.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.